| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.
|
Arch Intern Med
|
2005
|
6.02
|
|
2
|
Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy.
|
J Clin Oncol
|
2006
|
3.09
|
|
3
|
Androgen levels in older men who have or who are at risk of acquiring HIV infection.
|
Clin Infect Dis
|
2005
|
2.55
|
|
4
|
Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.
|
AIDS
|
2005
|
2.54
|
|
5
|
Endogenous sex hormones and glucose tolerance status in postmenopausal women.
|
J Clin Endocrinol Metab
|
2007
|
2.29
|
|
6
|
Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.
|
Cancer
|
2006
|
2.10
|
|
7
|
Sex-based differences in pain perception and treatment.
|
Pain Med
|
2009
|
1.82
|
|
8
|
The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women.
|
J Clin Endocrinol Metab
|
2009
|
1.71
|
|
9
|
Long-term effects of androgen deprivation therapy in prostate cancer patients.
|
Clin Endocrinol (Oxf)
|
2002
|
1.64
|
|
10
|
Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy.
|
J Urol
|
2009
|
1.44
|
|
11
|
Endocrine effects of marijuana.
|
J Clin Pharmacol
|
2002
|
1.35
|
|
12
|
Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
|
J Clin Endocrinol Metab
|
2004
|
1.32
|
|
13
|
Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study.
|
J Clin Endocrinol Metab
|
2004
|
1.29
|
|
14
|
Androgen deficiency, diabetes, and the metabolic syndrome in men.
|
Curr Opin Endocrinol Diabetes Obes
|
2007
|
1.26
|
|
15
|
Klinefelter syndrome: expanding the phenotype and identifying new research directions.
|
Genet Med
|
2003
|
1.21
|
|
16
|
Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection.
|
J Acquir Immune Defic Syndr
|
2011
|
1.17
|
|
17
|
Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis.
|
Diabetes Care
|
2009
|
1.14
|
|
18
|
Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy.
|
AIDS
|
2007
|
1.09
|
|
19
|
Male hypogonadism in systemic disease.
|
Endocrinol Metab Clin North Am
|
2007
|
1.09
|
|
20
|
Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: the impact of gender and injection drug use.
|
J Neurovirol
|
2005
|
1.08
|
|
21
|
Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999.
|
Am J Epidemiol
|
2002
|
1.07
|
|
22
|
Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men.
|
J Acquir Immune Defic Syndr
|
2006
|
1.07
|
|
23
|
Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substudy of the Multicenter AIDS Cohort Study.
|
AIDS Res Ther
|
2009
|
0.98
|
|
24
|
New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.
|
J Clin Endocrinol Metab
|
2004
|
0.97
|
|
25
|
Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.
|
J Gerontol A Biol Sci Med Sci
|
2011
|
0.96
|
|
26
|
Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease.
|
Clin Infect Dis
|
2003
|
0.95
|
|
27
|
Topical testosterone supplementation for the treatment of male hypogonadism.
|
Drugs
|
2012
|
0.94
|
|
28
|
The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III).
|
Clin Endocrinol (Oxf)
|
2011
|
0.93
|
|
29
|
Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir.
|
BMC Complement Altern Med
|
2008
|
0.93
|
|
30
|
The effect of androgens on lipids.
|
Curr Opin Endocrinol Diabetes Obes
|
2013
|
0.90
|
|
31
|
Gonadal and Adrenal Abnormalities in Drug Users: Cause or Consequence of Drug Use Behavior and Poor Health Outcomes.
|
Am J Infect Dis
|
2006
|
0.88
|
|
32
|
Body composition, gender, and illicit drug use in an urban cohort.
|
Am J Drug Alcohol Abuse
|
2007
|
0.87
|
|
33
|
Lipodystrophy and inflammation predict later grip strength in HIV-infected men: the MACS Body Composition substudy.
|
AIDS Res Hum Retroviruses
|
2013
|
0.87
|
|
34
|
Relation between duration of androgen deprivation therapy and degree of insulin resistance in men with prostate cancer.
|
Arch Intern Med
|
2007
|
0.86
|
|
35
|
Effects of testosterone on body composition of the aging male.
|
Mech Ageing Dev
|
2004
|
0.85
|
|
36
|
Prevalence of low bone mineral density in a low-income inner-city population.
|
J Bone Miner Res
|
2011
|
0.85
|
|
37
|
Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism.
|
Expert Opin Pharmacother
|
2005
|
0.83
|
|
38
|
Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III).
|
Aging Male
|
2012
|
0.83
|
|
39
|
Hypothalamic-pituitary-gonadal function in men and women using heroin and cocaine, stratified by HIV status.
|
Gend Med
|
2007
|
0.83
|
|
40
|
Clinicians' attitudes and usage of complementary and alternative integrative medicine: a survey at the Johns Hopkins Medical Institute.
|
J Altern Complement Med
|
2007
|
0.83
|
|
41
|
Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study.
|
J Urol
|
2008
|
0.83
|
|
42
|
Handedness, functional cerebral hemispheric lateralization, and cognition in male-to-female transsexuals receiving cross-sex hormone treatment.
|
Arch Sex Behav
|
2005
|
0.83
|
|
43
|
Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial.
|
J Androl
|
2010
|
0.82
|
|
44
|
Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism.
|
AIDS Res Ther
|
2014
|
0.82
|
|
45
|
Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men.
|
AIDS
|
2014
|
0.82
|
|
46
|
Testosterone making an entry into the cardiometabolic world.
|
Circulation
|
2007
|
0.82
|
|
47
|
Elevated HDL cholesterol levels are associated with osteoporosis in lung transplant candidates with chronic obstructive pulmonary disease.
|
Respir Med
|
2010
|
0.81
|
|
48
|
Effect of methyl testosterone administration on plasma viscosity in postmenopausal women.
|
Clin Endocrinol (Oxf)
|
2002
|
0.81
|
|
49
|
Cortisol levels and depression in men and women using heroin and cocaine.
|
Psychoneuroendocrinology
|
2005
|
0.81
|
|
50
|
Current and future testosterone delivery systems for treatment of the hypogonadal male.
|
Expert Opin Drug Deliv
|
2008
|
0.80
|
|
51
|
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.
|
Clin Cardiol
|
2003
|
0.79
|
|
52
|
Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women.
|
J Clin Endocrinol Metab
|
2006
|
0.78
|
|
53
|
Association between sex steroid hormones and hematocrit in a nationally representative sample of men.
|
J Androl
|
2012
|
0.78
|
|
54
|
Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III.
|
Cancer Causes Control
|
2010
|
0.77
|
|
55
|
The effects of illicit drug use and HIV infection on sex hormone levels in women.
|
Gynecol Endocrinol
|
2006
|
0.77
|
|
56
|
The challenges of randomized trials in integrative cancer care.
|
Integr Cancer Ther
|
2004
|
0.77
|
|
57
|
Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.
|
Future Oncol
|
2009
|
0.77
|
|
58
|
Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients.
|
Int J Gastrointest Cancer
|
2003
|
0.76
|
|
59
|
Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women.
|
Horm Res
|
2002
|
0.76
|
|
60
|
Omega-3 fatty acids for the treatment of cancer cachexia: issues in designing clinical trials of dietary supplements.
|
J Altern Complement Med
|
2005
|
0.76
|
|
61
|
New modalities of transdermal testosterone replacement.
|
Treat Endocrinol
|
2003
|
0.76
|
|
62
|
Relationship between sex hormones and cognitive performance in men with substance use.
|
Drug Alcohol Depend
|
2012
|
0.75
|
|
63
|
Point-counterpoint: using clinical trials for the evaluation of integrative cancer therapies.
|
Integr Cancer Ther
|
2004
|
0.75
|
|
64
|
Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men.
|
J Acquir Immune Defic Syndr
|
2016
|
0.75
|
|
65
|
Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men.
|
J Acquir Immune Defic Syndr
|
2015
|
0.75
|
|
66
|
Testosterone and Abnormal Glucose Metabolism in an Inner-City Cohort.
|
J Mens Health
|
2012
|
0.75
|
|
67
|
Streamlining the clinical research enterprise.
|
J Investig Med
|
2002
|
0.75
|
|
68
|
Safety and adverse effects of androgens: how to counsel patients.
|
Mayo Clin Proc
|
2004
|
0.75
|
|
69
|
Is hypogonadism a risk factor for sexual dysfunction?
|
J Androl
|
2003
|
0.75
|